Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6665)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2023 (publication date) through Oct 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343 [PMID: 37545640 DOI: 10.3748/wjg.v29.i27.4334] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm |
| Number | Citing Articles |
| 1 |
Qianyu Xie, Birong Liu, Xiao Yu, Xiang Wei, Qiangsheng Xiao, Minghua Ren. Integration of Immune Cell Signatures and Diagnostic Gene Markers in Pancreatitis: A Comprehensive Study on Therapeutic Targets and Predictive Diagnosis. Human Mutation 2025; 2025(1) doi: 10.1155/humu/7694723
|
| 2 |
Likang Xu, Jinzhao Zou, Chao Sun, Gong Chen, Sujun Gao. Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1441785
|
| 3 |
|
| 4 |
Zong-Qiang Han, Li-Na Wen. Tofacitinib for ulcerative colitis: A promising treatment option. World Journal of Gastroenterology 2024; 30(40): 4386-4392 doi: 10.3748/wjg.v30.i40.4386
|
| 5 |
Yi-Fang Zhang, Ting Ting Shi, Yi-Ling Lin, Yu-Ting Zhu, Shu Lin, Tai-Yong Fang. Macrophage Metabolic Reprogramming in Inflammatory Bowel Diseases: From Pathogenesis to Therapy. Journal of Inflammation Research 2025; : 11821 doi: 10.2147/JIR.S534447
|
| 6 |
Abdulrhman Al Abdulqader, Jawad S. Alnajjar, Lama Alzimami, Reem AlQarni, Fathima Raahima Riyas Mohamed, Rana AlQarni, Jomana Alnasser, Doaa Alabdulkarim, Abdullah Almaqhawi, Mohammed Abdullah Albesher, Ahmed Albadrani. Relapse Rates and Predictors Following Azathioprine Withdrawal in Inflammatory Bowel Disease: A Systematic Review, Meta-Analysis, and Meta-Regression. Journal of Clinical Medicine 2025; 14(19): 6868 doi: 10.3390/jcm14196868
|
| 7 |
Gulshan Rathi, Prashant B. Shamkuwar, Karishma Rathi, Ruchita Ranazunjare, Soham Kulkarni. Contemporary and prospective use of azathioprine (AZA) in viral, rheumatic, and dermatological disorders: a review of pharmacogenomic and nanotechnology applications. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(4): 3183 doi: 10.1007/s00210-024-03569-8
|